[HTML][HTML] Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis.
H Kim, J Oh, S Lee, J Ha, M Yoon, K Chun… - Scientific …, 2021 - search.ebscohost.com
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
H Kim, J Oh, S Lee, J Ha, M Yoon… - Scientific …, 2021 - yonsei.elsevierpure.com
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
H Kim, J Oh, S Lee, J Ha, M Yoon… - Scientific …, 2021 - pubmed.ncbi.nlm.nih.gov
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis.
H Kim, J Oh, S Lee, J Ha, M Yoon, KH Chun… - Scientific …, 2021 - europepmc.org
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
[HTML][HTML] Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
H Kim, J Oh, S Lee, J Ha, M Yoon, K Chun… - Scientific …, 2021 - ncbi.nlm.nih.gov
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
H Kim, J Oh, S Lee, J Ha, M Yoon, K Chun… - Scientific …, 2021 - ui.adsabs.harvard.edu
Sacubitril/valsartan is superior to enalapril in reducing the risks of cardiovascular death and
preventing hospitalization in patients with heart failure and reduced ejection fraction …
preventing hospitalization in patients with heart failure and reduced ejection fraction …
[PDF][PDF] Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
H Kim, J Oh, S Lee, J Ha, M Yoon, K Chun, CJ Lee… - Scientific …, 2021 - academia.edu
Methods Study population. This study was a single-center, prospective, observational study
conducted at a tertiary university hospital 12, 13. The consecutive outpatients (≥ 18 years …
conducted at a tertiary university hospital 12, 13. The consecutive outpatients (≥ 18 years …